Management of Retroperitoneal Hematoma
Immediately assess hemodynamic stability and obtain CT angiography (CTA) of the abdomen/pelvis with IV contrast in stable patients, while unstable patients require urgent operative intervention without imaging. 1, 2
Initial Stabilization and Assessment
Hemodynamic Assessment:
- Check vital signs, signs of hypovolemia (tachycardia, hypotension, altered mental status), and severity of ongoing blood loss immediately upon presentation 1
- Establish large-bore IV access (two lines minimum) and initiate aggressive fluid resuscitation if any signs of instability are present 1
- Maintain body temperature >36°C as hypothermia impairs clotting factor function 1
Laboratory Studies:
- Obtain complete blood count, coagulation profile (PT/INR, aPTT), fibrinogen level, and type and crossmatch for blood products 1
- Monitor serial hematocrit levels, as retroperitoneal hematomas can sequester >2 liters of blood without obvious external bleeding 1
Diagnostic Imaging Strategy
For Hemodynamically Stable Patients:
- CTA of abdomen/pelvis with IV contrast is the diagnostic modality of choice, detecting bleeding rates as slow as 0.3 mL/min and providing detailed vascular anatomy 3, 2
- CTA identifies active extravasation (contrast blush), pseudoaneurysms, arteriovenous fistulas, hematoma size, and bleeding source 3, 2
- CT findings indicate acuity: high attenuation = acute bleeding; mixed attenuation = rebleeding; low attenuation = subacute/chronic blood 2
- Non-contrast CT alone is appropriate only when renal function is compromised or subsequent angiography is anticipated 2
For Hemodynamically Unstable Patients:
- Proceed directly to surgical exploration without imaging 1
- Do not delay operative intervention while pursuing diagnostic studies 1
Imaging Modalities to Avoid:
- Ultrasound is NOT appropriate due to limited acoustic windows and inability to reliably evaluate the entire retroperitoneum 3, 2
- Plain radiography has low sensitivity and is usually not appropriate, as moderate-volume hematomas may not produce sufficient mass effect 2
Management Algorithm Based on Hemodynamic Status
Hemodynamically Stable Patients WITH Active Bleeding on CTA
Super-selective angioembolization is first-line treatment:
- Indicated for arterial contrast extravasation, pseudoaneurysms, arteriovenous fistula, or non-self-limiting gross hematuria 2
- Achieves cessation of bleeding in nearly 100% of cases when active bleeding is identified on angiography 1, 2
- Perform as selectively as possible to preserve organ function 2
- Do NOT perform blind angioembolization in stable patients with negative angiography, regardless of CT findings 2
Hemodynamically Stable Patients WITHOUT Active Bleeding on CTA
Conservative management with close monitoring:
- Serial clinical examinations, laboratory monitoring (hematocrit every 4-6 hours initially), and blood pressure monitoring 2
- Follow-up CT appropriate to evaluate for rebleeding, changes in hematoma size, or complications such as infection 2
- This approach is successful in patients without signs of contrast extravasation or low-flow active bleeding 4
Hemodynamically Unstable Patients
Immediate operative intervention is mandatory:
- Unresponsive to volume resuscitation requires urgent surgery 2
- Pulsatile or expanding retroperitoneal hematoma discovered during laparotomy mandates exploration 2
- Uncontrollable life-threatening hemorrhage with renal pedicle avulsion or renal vein lesion requires urgent operative intervention 2
Special Consideration: Anticoagulated Patients
Reversal of Anticoagulation:
- For warfarin: discontinue immediately and administer vitamin K1 (5-25 mg parenteral, rarely up to 50 mg) for major bleeding 5
- In severe hemorrhage, administer fresh frozen plasma (200-500 mL) or commercial Factor IX complex to restore clotting factors to normal 5
- Caution: Factor IX complex carries increased risk of thrombosis and should be used only in life-threatening bleeding 5
- Anticoagulation is a major cause of spontaneous retroperitoneal hemorrhage, particularly with excessive anticoagulation 6
Blood Product Transfusion Protocol
Massive Hemorrhage Protocol:
- Transfuse packed red blood cells, fresh frozen plasma, and platelets in a 1:1:1 ratio 1
- Administer tranexamic acid 1g IV over 10 minutes within 1-3 hours of bleeding onset, followed by 1g infused over 8 hours 3, 1
- Transfuse based on clinical presentation and hemodynamic instability, not arbitrary hemoglobin thresholds 1
Goal-Directed Coagulation Management:
- Administer fibrinogen concentrate 3-4g initially if fibrinogen <1.5-2.0 g/L, guided by viscoelastic monitoring 3
- Maintain platelet count >50 × 10⁹/L (>100 × 10⁹/L if traumatic brain injury present) 3
- Maintain ionized calcium within normal range; administer calcium chloride to correct hypocalcemia 3
Specific Interventions to AVOID
- Never aspirate retroperitoneal hematomas, as this does not address underlying vascular injury and can introduce infection 1
- Packing alone is insufficient, as it does not control arterial bleeding sources and may delay definitive treatment 1
- Do not underestimate blood loss; retroperitoneal space can accommodate massive volumes without external signs 1
Special Clinical Scenarios
Pelvic Fracture-Associated Hematomas:
- Represent 55% of blunt trauma cases and require higher transfusion volumes 2, 6
- Apply pelvic binder in pre-hospital setting to limit life-threatening bleeding 3
- Early pelvic ring closure and stabilization for patients in hemorrhagic shock 3
Penetrating Trauma:
- Requires exploration if not adequately studied preoperatively 2
Renal Injuries:
- Shattered kidney or pyelo-ureteral junction avulsion in stable patients does NOT mandate urgent surgical intervention 2
- Urine extravasation alone is not an indication for operative management acutely 2
Critical Pitfalls
- Never delay surgical intervention in unstable patients while pursuing imaging or conservative measures 1
- Early diagnosis within first 5 hours significantly improves outcomes 2
- Routine physical examinations and sequential hematocrit monitoring are essential, especially in patients with altered mental status 7
- Diagnosis can be delayed due to nonspecific signs (diffuse abdominal pain, back pain, flank mass) 6